Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: A comparative study

Annals of the Rheumatic Diseases

Volumn 71, Issue 12, 2012, Pages 1991-1997

  Gerss, Joachim ^a   Roth, Johannes ^a   Holzinger, Dirk ^a,b   Ruperto, Nicolino ^c   Wittkowski, Helmut ^b   Frosch, Michael ^b   Wulffraat, Nico ^d   Wedderburn, Lucy ^e   Stanevicha, Valda ^f   Mihaylova, Dimitrina ^g   Harjacek, Miroslav ^h   Len, Claudio ⁱ   Toppino, Claudia ^j   Masi, Massimo ^k   Minden, Kirsten ^l   Saurenmann, Traudel ^m   Uziel, Yosef ⁿ   Vesely, Richard ^o   Apaz, Maria Teresa ^p   Kuester, Rolf Michael ^q   Elorduy, Maria Jesus Rua ^r   Burgos Vargas, Ruben ^s   Ioseliani, Maka ^t   Magni Manzoni, Silvia ^u   Unsal, Erbil ^v   Anton, Jordi ^w   Balogh, Zsolt ^x   Hagelberg, Stefan ^y   Mazur Zielinska, Henryka ^z   Tauber, Tsivia ^aa   Martini, Alberto ^c,ab   Foell, Dirk ^a   more..

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c G GASLINI INSTITUTE   (Italy)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f RIGA STRADINS UNIVERSITY   (Latvia)

^g University Children Hospital   (Bulgaria)

^h Croatia   (Croatia)

ⁱ FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^j UNIVERSITY OF TURIN   (Italy)

^k UNIVERSITY OF BOLOGNA   (Italy)

^l CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^m UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

ⁿ MEIR MEDICAL CENTER   (Israel)

^o 1st Pediatric Dept   (Slovakia)

^p UNIVERSIDAD CATÓLICA DE CÓRDOBA   (Argentina)

^q Rheumaklinik Bad Bramstedt   (Germany)

^r HOSPITAL DE CRUCES   (Spain)

^s HOSPITAL GENERAL DE MÉXICO   (Mexico)

^t Center of Rheumatology   (Georgia)

^u FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^v DOKUZ EYLUL UNIVERSITY   (Turkey)

^w HOSPITAL SANT JOAN DE DÉU   (Spain)

^x NATIONAL INSTITUTE OF RHEUMATOLOGY AND PHYSIOTHERAPY   (Hungary)

^y KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^z MEDICAL UNIVERSITY OF SILESIA   (Poland)

^aa Asaf Harofe Medical Center   (Israel)

^ab UNIVERSITY OF GENOA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; MYELOID RELATED PROTEIN 14; MYELOID RELATED PROTEIN 8; PROTEIN S 100; UNCLASSIFIED DRUG;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE MARKER; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; PHAGOCYTOSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; REMISSION; RISK FACTOR; SENSITIVITY ANALYSIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALGRANULIN A; CALGRANULIN B; CHILD; DRUG MONITORING; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; PHAGOCYTES; RECURRENCE; REMISSION INDUCTION; RISK FACTORS; S100 PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 84868453277     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-201329     Document Type: Article

References (21)

1. Woo P, Wedderburn LR. Juvenile chronic arthritis. Lancet 1998;351:969-73.
2. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007;369:767-78.
3. Wallace CA, Huang B, Bandeira M, et al. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum 2005;52:3554-62.
4. Wallace CA, Ravelli A, Huang B, et al. Preliminary validation of clinical remission criteria using the OMERACT filter for select categories of juvenile idiopathic arthritis. J Rheumatol 2006;33:789-95.
5. Wallace CA, Sherry DD, Mellins ED, et al. Predicting remission in juvenile rheumatoid arthritis with methotrexate treatment. J Rheumatol 1993;20:118-22.
6. Wallace CA, Ruperto N, Giannini E; Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology International Trials Organization; Pediatric Rheumatology Collaborative Study Group. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004;31:2290-4.
7. Foell D, Wulffraat N, Wedderburn LR, et al.; Paediatric Rheumatology International Trials Organization (PRINTO). Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA 2010;303:1266-73.
8. Hofmann MA, Drury S, Fu C, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999;97:889-901.
9. Wittkowski H, Sturrock A, van Zoelen MA, et al. Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome. Crit Care Med 2007;35:1369-75.
10. Foell D, Wittkowski H, Roth J. Mechanisms of disease: a 'DAMP' view of inflammatory arthritis. Nat Clin Pract Rheumatol 2007;3:382-90.
11. Vogl T, Tenbrock K, Ludwig S, et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 2007;13:1042-9.
12. Wittkowski H, Foell D, af Klint E, et al. Effects of intra-articular corticosteroids and anti-TNF therapy on neutrophil activation in rheumatoid arthritis. Ann Rheum Dis 2007;66:1020-5.
13. Foell D, Roth J. Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum 2004;50:3762-71.
14. Wallace CA, Giannini EH, Huang B, et al.; Childhood Arthritis Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Paediatric Rheumatology International Trials Organisation. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2011;63:929-36.
15. Foell D, Frosch M, Sorg C, et al. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta 2004;344:37-51.
16. Youden WJ. Index for rating diagnostic tests. Cancer 1950;3:32-5.
17. Bossuyt PM, Reitsma JB; Standards for Reporting of Diagnostic Accuracy. The STARD initiative. Lancet 2003;361:71.
18. Schulze zur Wiesch A, Foell D, Frosch M, et al. Myeloid related proteins MRP8/MRP14 may predict disease flares in juvenile idiopathic arthritis. Clin Exp Rheumatol 2004;22:368-73.
19. Foell D, Frosch M, Schulze zur Wiesch A, et al. Methotrexate treatment in juvenile idiopathic arthritis: when is the right time to stop? Ann Rheum Dis 2004;63:206-8.
20. Foell D, Wittkowski H, Hammerschmidt I, et al. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthritis Rheum 2004;50:1286-95.
21. Beukelman T, Cron RQ, Patkar NM, et al. Reply. Arthritis Care Res 2011;63:1355-6.